OTC : BDRFY
-$0.13 (-0.71%)
| Source | Headline |
|---|---|
|
Beiersdorf: Cutting The Stock In Half Made It A Cautious 'Buy' (Rating Upgrade)
Beiersdorf is now fairly valued after a significant decline, with an intrinsic value estimated at €68.85 per share. Recent results show organic growth of 2.4% in 2025, but Q1 2026 saw a 4.6% organic sales decline, with Nivea under particular pressure. Management maintains flat-to-slightly-positive 2026 guidance, citing Derma segment strength and early signs of Nivea recovery, despite analyst skepticism. seekingalpha.com - 2026-06-10 08:09:39 |
|
Beiersdorf Aktiengesellschaft (BDRFY) Q1 2026 Earnings Call Transcript
Beiersdorf Aktiengesellschaft (BDRFY) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-04-21 08:11:45 |